174 related articles for article (PubMed ID: 30114927)
1. DCE-MR imaging of orbital lesions: diagnostic performance of the tumor flow residence time τ calculated by a multi-compartmental pharmacokinetic tumor model based on individual factors.
Erb-Eigner K; Asbach P; Ro SR; Haas M; Bertelmann E; Pietsch H; Schwenke C; Taupitz M; Denecke T; Hamm B; Lawaczeck R
Acta Radiol; 2019 May; 60(5):643-652. PubMed ID: 30114927
[TBL] [Abstract][Full Text] [Related]
2. Characterization of orbital masses by multiparametric MRI.
Ro SR; Asbach P; Siebert E; Bertelmann E; Hamm B; Erb-Eigner K
Eur J Radiol; 2016 Feb; 85(2):324-36. PubMed ID: 26781137
[TBL] [Abstract][Full Text] [Related]
3. Combined diffusion-weighted imaging and dynamic contrast-enhanced MRI for differentiating radiologically indeterminate malignant from benign orbital masses.
Xu XQ; Qian W; Ma G; Hu H; Su GY; Liu H; Shi HB; Wu FY
Clin Radiol; 2017 Oct; 72(10):903.e9-903.e15. PubMed ID: 28501096
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic approach for dynamic breast MRI to indicate signal intensity time curves of benign and malignant lesions by using the tumor flow residence time.
Renz DM; Diekmann F; Schmitzberger FF; Pietsch H; Fallenberg EM; Durmus T; Huppertz A; Böttcher J; Bick U; Hamm B; Lawaczeck R
Invest Radiol; 2013 Feb; 48(2):69-78. PubMed ID: 23262793
[TBL] [Abstract][Full Text] [Related]
5. Dynamic contrast-enhanced MRI of orbital and anterior visual pathway lesions.
Jittapiromsak N; Hou P; Liu HL; Sun J; Schiffman JS; Chi TL
Magn Reson Imaging; 2018 Sep; 51():44-50. PubMed ID: 29709464
[TBL] [Abstract][Full Text] [Related]
6. Orbital benign and malignant lymphoproliferative disorders: Differentiation using semi-quantitative and quantitative analysis of dynamic contrast-enhanced magnetic resonance imaging.
Hu H; Xu XQ; Liu H; Hong XN; Shi HB; Wu FY
Eur J Radiol; 2017 Mar; 88():88-94. PubMed ID: 28189215
[TBL] [Abstract][Full Text] [Related]
7. Dynamic contrast-enhanced MRI in orbital lymphoproliferative disorders: Effects of region of interest selection methods on time efficiency, measurement reproducibility, and diagnostic ability.
Qian W; Xu XQ; Hu H; Su GY; Wu JF; Shi HB; Wu FY
J Magn Reson Imaging; 2018 May; 47(5):1298-1305. PubMed ID: 28922524
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic performance of diffusion-weighted (DWI) and dynamic contrast-enhanced (DCE) MRI for the differentiation of benign from malignant soft-tissue tumors.
Choi YJ; Lee IS; Song YS; Kim JI; Choi KU; Song JW
J Magn Reson Imaging; 2019 Sep; 50(3):798-809. PubMed ID: 30663160
[TBL] [Abstract][Full Text] [Related]
9. Benign and malignant orbital lymphoproliferative disorders: Differentiating using multiparametric MRI at 3.0T.
Xu XQ; Hu H; Liu H; Wu JF; Cao P; Shi HB; Wu FY
J Magn Reson Imaging; 2017 Jan; 45(1):167-176. PubMed ID: 27299917
[TBL] [Abstract][Full Text] [Related]
10. Assessment of dynamic contrast-enhanced magnetic resonance imaging in the differentiation of malignant from benign orbital masses.
Yuan Y; Kuai XP; Chen XS; Tao XF
Eur J Radiol; 2013 Sep; 82(9):1506-11. PubMed ID: 23561057
[TBL] [Abstract][Full Text] [Related]
11. Differentiation of Benign from Malignant Adnexal Masses by Dynamic Contrast-Enhanced MRI (DCE-MRI): Quantitative and Semi-quantitative analysis at 3-Tesla MRI.
Gity M; Parviz S; Saligheh Rad H; Fathi Kazerooni A; Shirali E; Shakiba M; Baikpour M
Asian Pac J Cancer Prev; 2019 Apr; 20(4):1073-1079. PubMed ID: 31030476
[TBL] [Abstract][Full Text] [Related]
12. Quality-based pharmacokinetic model selection on DCE-MRI for characterizing orbital lesions.
Lecler A; Balvay D; Cuenod CA; Marais L; Zmuda M; Sadik JC; Galatoire O; Farah E; El Methni J; Zuber K; Bergès O; Savatovsky J; Fournier L
J Magn Reson Imaging; 2019 Nov; 50(5):1514-1525. PubMed ID: 30989761
[TBL] [Abstract][Full Text] [Related]
13. Optimized Fast Dynamic Contrast-Enhanced Magnetic Resonance Imaging of the Prostate: Effect of Sampling Duration on Pharmacokinetic Parameters.
Othman AE; Falkner F; Martirosian P; Schraml C; Schwentner C; Nickel D; Nikolaou K; Notohamiprodjo M
Invest Radiol; 2016 Feb; 51(2):106-12. PubMed ID: 26447494
[TBL] [Abstract][Full Text] [Related]
14. 3-T dynamic contrast-enhanced MRI of the breast: pharmacokinetic parameters versus conventional kinetic curve analysis.
El Khouli RH; Macura KJ; Kamel IR; Jacobs MA; Bluemke DA
AJR Am J Roentgenol; 2011 Dec; 197(6):1498-505. PubMed ID: 22109308
[TBL] [Abstract][Full Text] [Related]
15. Multiparametric quantitative analysis of tumor perfusion and diffusion with 3T MRI: differentiation between benign and malignant soft tissue tumors.
Lee SK; Jee WH; Jung CK; Chung YG
Br J Radiol; 2020 Nov; 93(1115):20191035. PubMed ID: 32649224
[TBL] [Abstract][Full Text] [Related]
16. Quantitative dynamic contrast-enhanced MR imaging analysis of complex adnexal masses: a preliminary study.
Thomassin-Naggara I; Balvay D; Aubert E; Daraï E; Rouzier R; Cuenod CA; Bazot M
Eur Radiol; 2012 Apr; 22(4):738-45. PubMed ID: 22105841
[TBL] [Abstract][Full Text] [Related]
17. Multiparametric approach with diffusion-weighted imaging and dynamic contrast-enhanced MRI: a comparison study for differentiating between benign and malignant bone lesions in adults.
Oh E; Yoon YC; Kim JH; Kim K
Clin Radiol; 2017 Jul; 72(7):552-559. PubMed ID: 28325514
[TBL] [Abstract][Full Text] [Related]
18. Differentiating between benign and malignant sinonasal lesions using dynamic contrast-enhanced MRI and intravoxel incoherent motion.
Jiang J; Xiao Z; Tang Z; Zhong Y; Qiang J
Eur J Radiol; 2018 Jan; 98():7-13. PubMed ID: 29279173
[TBL] [Abstract][Full Text] [Related]
19. [Diffusion weighted imaging and perfusion weighted imaging in the differential diagnosis of benign and malignant renal masses on 3.0 T MRI].
Xu X; Wang P; Ma L; Shao Z; Zhang M
Zhonghua Yi Xue Za Zhi; 2015 Jan; 95(3):200-4. PubMed ID: 25877031
[TBL] [Abstract][Full Text] [Related]
20. Histogram analysis of dynamic contrast-enhanced magnetic resonance imaging for differentiating malignant from benign orbital lymphproliferative disorders.
Xu XQ; Qian W; Hu H; Su GY; Liu H; Shi HB; Wu FY
Acta Radiol; 2019 Feb; 60(2):239-246. PubMed ID: 29804475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
